Search

Author/Creator Leflein, Jeffrey

1. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 10356 (17th September 2022)

Authors:
Paller, Amy S; Simpson, Eric L; Siegfried, Elaine C; Cork, Michael J; Wollenberg, Andreas; Arkwright, Peter D; Soong, Weily; Gonzalez, Mercedes E; Schneider, Lynda C; Sidbury, Robert; Lockshin, Benjamin; Meltzer, Steven; Wang, Zhixiao; Mannent, Leda P; Amin, Nikhil; Sun, Yiping; Laws, Elizabeth; ...
Journal:
Lancet
Issue:
Volume 400:Issue 10356(2022)
Page Start:
908
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial. Issue 3 (March 2021)

Authors:
Harrison, Tim W; Chanez, Pascal; Menzella, Francesco; Canonica, Giorgio Walter; Louis, Renaud; Cosio, Borja G; Lugogo, Njira L; Mohan, Arjun; Burden, Annie; McDermott, Lawrence; Garcia Gil, Esther; Zangrilli, James G; Pohl, Wolfgang; Voves, Robert; Deschampheleire, Maud; Louis, Renaud; Martinot, ...
Journal:
Lancet
Issue:
Volume 9:Issue 3(2021)
Page Start:
260
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search